GAMCO Investors’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-22,000
| Closed | -$138K | – | 928 |
|
|
2019
Q2 | $138K | Hold |
22,000
| – | – | ﹤0.01% | 899 |
|
|
2019
Q1 | $122K | Buy |
22,000
+2,000
| +10% | +$11.1K | ﹤0.01% | 827 |
|
|
2018
Q4 | $133K | Hold |
20,000
| – | – | ﹤0.01% | 776 |
|
|
2018
Q3 | $213K | Buy |
20,000
+4,000
| +25% | +$42.6K | ﹤0.01% | 795 |
|
|
2018
Q2 | $192K | Buy |
16,000
+800
| +5% | +$9.6K | ﹤0.01% | 821 |
|
|
2018
Q1 | $130K | Buy |
15,200
+600
| +4% | +$5.13K | ﹤0.01% | 818 |
|
|
2017
Q4 | $144K | Hold |
14,600
| – | – | ﹤0.01% | 817 |
|
|
2017
Q3 | $179K | Hold |
14,600
| – | – | ﹤0.01% | 814 |
|
|
2017
Q2 | $240K | Hold |
14,600
| – | – | ﹤0.01% | 784 |
|
|
2017
Q1 | $209K | Hold |
14,600
| – | – | ﹤0.01% | 789 |
|
|
2016
Q4 | $202K | Hold |
14,600
| – | – | ﹤0.01% | 775 |
|
|
2016
Q3 | $264K | Sell |
14,600
-1,500
| -9% | -$27.1K | ﹤0.01% | 751 |
|
|
2016
Q2 | $231K | Hold |
16,100
| – | – | ﹤0.01% | 768 |
|
|
2016
Q1 | $192K | Hold |
16,100
| – | – | ﹤0.01% | 763 |
|
|
2015
Q4 | $214K | Buy |
16,100
+1,815
| +13% | +$24.1K | ﹤0.01% | 762 |
|
|
2015
Q3 | $153K | Hold |
14,285
| – | – | ﹤0.01% | 795 |
|
|
2015
Q2 | $115K | Sell |
14,285
-744
| -5% | -$5.99K | ﹤0.01% | 812 |
|
|
2015
Q1 | $99K | Hold |
15,029
| – | – | ﹤0.01% | 820 |
|
|
2014
Q4 | $96K | Sell |
15,029
-7,857
| -34% | -$50.2K | ﹤0.01% | 846 |
|
|
2014
Q3 | $226K | Hold |
22,886
| – | – | ﹤0.01% | 821 |
|
|
2014
Q2 | $258K | Buy |
22,886
+2,429
| +12% | +$27.4K | ﹤0.01% | 811 |
|
|
2014
Q1 | $248K | Hold |
20,457
| – | – | ﹤0.01% | 786 |
|
|
2013
Q4 | $258K | Hold |
20,457
| – | – | ﹤0.01% | 770 |
|
|
2013
Q3 | $341K | Hold |
20,457
| – | – | ﹤0.01% | 727 |
|
|
2013
Q2 | $311K | Buy |
+20,457
| New | +$311K | ﹤0.01% | 720 |
|